ad image

Respiratory Syncytial Virus

1 / 1
Nuance Pharma
License Agreement

Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of RSV Vaccine for Adults in China

Nuance Pharma

PR-M03-22-08Mar 21, 2022
Pfizer
Clinical Study

Pfizer Begins a Phase 1/2 Study to Evaluate Respiratory Syncytial Virus (RSV) Vaccine

Pfizer

PR-M05-18-NI-092May 24, 2018
1 / 1